A man living with advanced liver cancer has seen his tumour shrink by over half in an “exciting” new clinical trial offering ...

Worldwide, hepatitis B virus is the major risk factor for hepatocellular carcinoma (HCC), owing to ... surveillance regimes of α-fetoprotein and ultrasound may be augmented by novel biomarkers ...

Hepatocellular carcinoma (HCC) is the third most common ... Current surveillance regimes of α-fetoprotein and ultrasound may be augmented by novel biomarkers of HCC discovered through new ...

Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...

Key search terms included Hepatocellular carcinoma, HCC, Liver cancer, Magnetic resonance imaging, MRI, radiomics, deep learning, machine learning, and artificial intelligence. Results: A ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer ... Screening and surveillance employ serological markers and imaging tools. Abdominal ultrasound is widely used, with ...